Skip to content

    Research Use Only

    This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.

    🔬 100K+ researchers trust BodyHackGuide — Join r/BodyHackGuide
    herbPreclinical

    Horny Goat Weed Dosage Guide: Protocols, Calculator & Safety

    Everything you need to know about Horny Goat Weed dosing — protocols, safety, and where to buy.

    Dosage Calculator

    Calculate exact dosing for Horny Goat Weed.

    Dosing Protocols

    Beginner

    Beginner Horny Goat Weed protocol (0-12 weeks). Start with a product that specifies icariin content — either whole leaf extract (typically 5-10% icariin) or a low-standardization extract (10% icariin). Avoid high-standardization products (40-98% icariin) at the beginner level; these provide too much active compound for initial titration. Starting dose: 250 mg once daily of a 10% icariin extract with breakfast for the first 7 days (containing approximately 25 mg icariin). This is a deliberately conservative starting dose to assess individual tolerance and screen for any unusual cardiovascular or psychoactive effects. If tolerated without significant side effects, advance to 250 mg twice daily (breakfast and lunch, totaling approximately 50 mg/day icariin) for weeks 2-4. By week 4, most beginners can stabilize at 250-500 mg twice daily (50-100 mg/day icariin) if continued effect is desired. This is a modest but evidence-supported dose for general use. Time of day: morning and midday dosing is preferred to avoid potential insomnia or evening agitation. Avoid dosing within 6 hours of bedtime at the beginner level. Take with food to reduce any GI upset, though absorption is modestly better on an empty stomach; the GI tolerance benefit usually outweighs the modest absorption reduction. For users with specific targets: for mild erectile dysfunction, the 50-100 mg/day icariin dose is a reasonable starting range, combined with foundational sexual function support (zinc, vitamin D, adequate sleep, exercise, stress management). For post-menopausal bone health, 100-200 mg/day icariin combined with vitamin D3, vitamin K2, calcium, magnesium, and resistance training is a reasonable beginner approach. For general men's health and libido, 50-100 mg/day icariin combined with foundational supplements is appropriate. Tracking: for sexual function targets, use validated scales like IIEF-5 (for men) at baseline and 12 weeks. For general libido, use simple 1-10 daily ratings. For cardiovascular safety, monitor home blood pressure and heart rate weekly for the first 4 weeks. For bone health targets, baseline bone density testing (DEXA scan) and re-testing at 12-18 months provides objective assessment of effect. Cycling: at the beginner level, cycling is not mandatory but 8 weeks on, 1-2 weeks off, is a reasonable conservative pattern. Avoid combination with other new supplements during the first 4 weeks — you need a clean signal to assess whether Horny Goat Weed is working for your specific situation. Avoid alcohol for the first 2-4 weeks and be particularly attentive to any cardiovascular symptoms. Do not combine with any pharmaceutical PDE5 inhibitor (Viagra, Cialis, Levitra) without medical supervision. Absolutely do not combine with nitrates (nitroglycerin) for any reason. If you experience significant palpitations, hypotension, severe headaches, significant mood changes, or chest pain, discontinue immediately and seek medical evaluation. The beginner protocol is designed to answer "does Horny Goat Weed help me, safely?" within 12 weeks.

    Standard

    Intermediate Horny Goat Weed protocol (weeks 12-52, specific clinical target). The intermediate protocol assumes you have confirmed tolerance and partial or full response at the beginner level and are pursuing a defined goal: clinically meaningful improvement in mild-to-moderate erectile dysfunction, long-term bone density support in post-menopausal women or men with osteopenia, comprehensive male hormonal optimization as part of a stack approach, or general cardiovascular and cognitive resilience. Dose: 500 mg twice daily of a 20% icariin extract, totaling approximately 200 mg/day icariin. This is the dose range most commonly used in the positive clinical trials for both ED and osteoporosis. Alternatively, for higher-concentration products, 250 mg twice daily of a 40% icariin extract provides similar total icariin exposure. For users who tolerate it well, advance to 500 mg three times daily of a 20% extract for specific targets, providing approximately 300 mg/day icariin. Timing: morning, midday, and mid-afternoon (at least 6 hours before bedtime). Consistency matters for chronic effects. Take with food. For users specifically targeting erectile dysfunction, timing relative to sexual activity matters less than with pharmaceutical PDE5 inhibitors — Epimedium works primarily through chronic modulation rather than acute pre-activity dosing — but some users report subjective benefit with pre-activity dosing 30-60 minutes before anticipated intimacy. Cycling at the intermediate stage: 12 weeks on, 2-3 weeks off, is a reasonable pattern, or continuous use with periodic reassessment. Unlike some dopaminergic or stimulant herbs, Epimedium does not appear to develop strong tolerance with continuous use, though annual reassessment is valuable to confirm ongoing benefit. Monitoring: home blood pressure and heart rate 2-3 times per week throughout, annual comprehensive metabolic panel and lipid panel, annual cardiovascular risk reassessment including resting ECG if not done recently, for post-menopausal bone health users DEXA scan at baseline and every 18-24 months for ongoing assessment, and for men on testosterone-focused protocols, serum total and free testosterone, SHBG, estradiol, LH, and FSH at baseline and at 6 months. Intermediate stacking: for erectile dysfunction — Horny Goat Weed 200 mg/day icariin + L-Citrulline 6-8 g/day + Zinc 30 mg/day + Tongkat Ali 200-400 mg/day + Shilajit 500 mg/day PrimaVie + Vitamin D3 to sufficiency (aim for 40-60 ng/ml serum 25-OH D3) + foundational diet, exercise, sleep, and stress management. For post-menopausal bone health — Horny Goat Weed 200-300 mg/day icariin + Vitamin D3 2000-5000 IU + Vitamin K2 MK-7 100-200 mcg + dietary calcium 1000-1200 mg (supplemental calcium only if dietary intake is inadequate; avoid high-dose supplemental calcium without vitamin D and K2 cofactors) + Magnesium 300-400 mg + Strontium citrate 340 mg (controversial, discuss with physician) + Omega-3 2-3 g/day + resistance training 2-3 times/week. For male hormonal optimization — Horny Goat Weed + Tongkat Ali + Ashwagandha KSM-66 + Shilajit + Zinc + Boron 6-10 mg/day + Vitamin D3 + lifestyle optimization. Coordinate with any treating physician, particularly if on cardiovascular or diabetes medications where hawthorn's hemodynamic effects may interact. The intermediate protocol is the level at which most of the controlled trial data sits and is appropriate for users pursuing specific clinical targets with reasonable seriousness.

    Advanced

    Advanced Horny Goat Weed protocol (year 2+, specific complex clinical applications). The advanced protocol is for users pursuing specific complex clinical indications, typically under integrative medicine supervision — refractory post-menopausal osteoporosis as complement to or alternative for pharmaceutical therapy (under medical supervision), significant male hypogonadism as part of a non-pharmaceutical optimization approach (discuss with endocrinologist), moderate-to-severe erectile dysfunction as part of a multi-modal approach, or comprehensive longevity protocols in men and women over 60. Dose: 500-1000 mg 2-3 times daily of a 40-60% icariin extract, totaling 400-1800 mg/day icariin. The upper end of this range is research-level dosing that has been used in specific clinical trials but is not appropriate for casual use. At these doses, all relevant monitoring intensifies: monthly home blood pressure and heart rate for the first 3 months; 3-monthly comprehensive metabolic panel; 6-monthly complete blood count; for bone-focused users, DEXA scan every 12-18 months with bone turnover markers (P1NP, CTX) at baseline and 6 months; for men on hormonal-focused protocols, serum total and free testosterone, SHBG, estradiol (sensitive assay), DHT, LH, FSH, and hematocrit (watch for testosterone-induced erythrocytosis) every 3-6 months; ECG at baseline and as clinically indicated; and medication reconciliation with all prescribing clinicians to identify interactions. Cycling at advanced doses: 12 weeks on, 3-4 weeks off, or longer continuous use with careful monitoring and periodic dose holidays. Advanced stacking for post-menopausal osteoporosis as alternative/adjunct to pharmaceutical therapy: Horny Goat Weed 400-800 mg/day icariin + full bone-health nutrient stack as in intermediate protocol + resistance and impact training + careful vitamin D optimization to 50-70 ng/ml + discussion with physician about potential combination with bisphosphonates or pharmaceutical SERMs. This should never be self-directed advanced management of osteoporosis; work with endocrinologist or integrative-minded primary care provider. Advanced stacking for severe ED or hypogonadism: Horny Goat Weed + Tongkat Ali + Shilajit + Ashwagandha at maximum evidence-based doses + L-Citrulline + Pine Bark Extract (Pycnogenol) + comprehensive lifestyle optimization + stress and sleep interventions + discussion with primary care provider about whether pharmaceutical therapy (PDE5 inhibitors, testosterone therapy) is appropriate as primary or adjunctive intervention. In these cases, "natural only" is often not the most effective approach — combining appropriate pharmaceutical therapy with supportive botanicals produces better outcomes than either alone. Advanced cardiovascular/longevity stack: Horny Goat Weed + Hawthorn + CoQ10 ubiquinol + L-Citrulline + Omega-3 + Vitamin K2 + Magnesium + Taurine + dietary nitrate (beetroot) + nattokinase (with caution if on anticoagulants). This provides broad cardiovascular support and has some preliminary evidence in aging populations but has not been formally studied as an integrated protocol. At the advanced level, drug interaction management is critical. Do not combine with pharmaceutical PDE5 inhibitors without explicit medical coordination. Absolutely avoid combining with nitrates (nitroglycerin, isosorbide dinitrate, isosorbide mononitrate). Monitor for additive effects with antihypertensive medications and adjust pharmaceutical doses as needed with clinical supervision. Be attentive to effects on anticoagulation if on warfarin or DOACs. Discontinue 2 weeks before elective surgery. For any acute cardiovascular event (chest pain, syncope, severe hypotension), inform emergency medical personnel about current Epimedium use — the PDE5 inhibition matters for emergency treatment decisions about nitrates and other vasodilators. A specific advanced consideration is long-term safety data: chronic use of icariin at high doses for more than 2-3 years has limited formal safety data, and the herb's hormonal and cardiovascular effects could theoretically accumulate over time in ways that are not well characterized. Reassess the risk-benefit calculation periodically and consider dose reduction or discontinuation if the primary clinical target is stable or if side effects emerge. Advanced users should also be aware of product adulteration risks — higher-concentration "icariin" products have occasionally been found contaminated with pharmaceutical PDE5 inhibitors (sildenafil, tadalafil, and their analogs), which would produce unexpectedly strong effects but also dangerous interactions. Buy only from manufacturers with published third-party testing for both potency and for pharmaceutical contamination.

    Commonly Stacked With

    Horny Goat Weed stacks well with other sexual function, hormonal support, and bone health compounds because its multi-mechanism profile — weak PDE5 inhibition, HPG axis support, SERM-like bone effects, and mild cardiovascular modulation — complements rather than duplicates most related compounds. The classical men's sexual function stack pairs Horny Goat Weed with Maca for non-hormonal libido support through endocannabinoid modulation (mechanistically distinct from Epimedium's PDE5 pathway), Tongkat Ali for free testosterone support through SHBG reduction, L-Citrulline 6-8 g/day for NO substrate provision (complements the eNOS-enhancing activity of icariin), Zinc 15-30 mg/day, and Shilajit 250-500 mg/day for testosterone support. This stack addresses erectile function (Horny Goat Weed via PDE5, L-Citrulline via NO substrate), libido (Maca), free testosterone (Tongkat Ali, Shilajit), and general reproductive health (Zinc). For users with moderate to significant sexual dysfunction, this stack at appropriate doses produces meaningful subjective improvements in 4-8 weeks. Add Mucuna Pruriens 1-3 g/day for dopaminergic libido and motivation enhancement if the user also reports reduced drive or motivation. A second important stack is for post-menopausal sexual function and hormonal support. Pair Horny Goat Weed with Red Clover (isoflavones for phytoestrogenic activity), Black Cohosh (for vasomotor symptoms and mood), Maca (non-hormonal libido), and Omega-3 2-3 g/day. This combination addresses hot flashes (Black Cohosh), general estrogenic support (Red Clover), bone health (Horny Goat Weed via SERM activity), libido (Maca), and cardiovascular support (Omega-3). For the bone-health-focused post-menopausal stack: Horny Goat Weed + Vitamin D3 2000-5000 IU + Vitamin K2 MK-7 100-200 mcg + Calcium 1000-1200 mg (from diet preferentially, supplemental if inadequate) + Magnesium 300-400 mg + Strontium (citrate, 340-680 mg, controversial but sometimes useful) + Omega-3 + resistance training. This is a comprehensive bone-resilience stack that complements or replaces pharmaceutical bisphosphonate or SERM therapy for milder cases under medical guidance. For male hormonal optimization beyond ED specifically, pair Horny Goat Weed with Tongkat Ali + Ashwagandha + Shilajit + Zinc + Vitamin D3 + Boron 6-10 mg/day (increases free testosterone via SHBG binding effects). This is essentially the evidence-based natural testosterone optimization stack and is appropriate for men with low-normal testosterone seeking natural support before considering pharmaceutical options. For cardiovascular resilience, Horny Goat Weed pairs with Hawthorn (complementary cardiotonic effects), CoQ10, Beetroot (dietary nitrates), L-Citrulline, and Omega-3. The NO-related mechanisms of these compounds work synergistically to support endothelial function and healthy blood pressure. For neuroprotective and cognitive-aging applications, layer Horny Goat Weed with Bacopa monnieri, Lion's Mane mushroom, Gotu Kola, Phosphatidylserine, and Omega-3 for a broad-spectrum cognitive-resilience stack appropriate for healthy aging. Avoid stacking Horny Goat Weed with pharmaceutical PDE5 inhibitors (Viagra, Cialis, Levitra) except under medical supervision — the additive effects can produce dangerous hypotension and priapism. Absolutely avoid combining with nitrates (nitroglycerin, isosorbide) — potentially fatal hypotension. Be cautious about combining with other strong sexual-function botanicals at maximum doses simultaneously (high-dose Tongkat Ali + high-dose Epimedium + high-dose Mucuna + Yohimbine is a recipe for cardiovascular overstimulation and potential arrhythmia in susceptible individuals). Start with one compound at a time and layer gradually over several weeks to assess individual response. For users with multiple cardiovascular medications (antihypertensives, nitrates, PDE5 inhibitors), discuss any Epimedium addition with the prescribing clinician before starting. The final principle: Horny Goat Weed is a legitimate, evidence-supported botanical for mild sexual dysfunction and bone health, but it works best as part of a comprehensive approach that includes appropriate foundational stacks (zinc, vitamin D, omega-3, protein, exercise, sleep) rather than as a single-herb attempt to address complex sexual or hormonal issues.

    Side Effects & Safety

    Horny Goat Weed (Epimedium) is generally well-tolerated at typical supplemental doses but is not a trivial herb — it has genuine cardiovascular, endocrine, and vascular effects that warrant attention to side effects, drug interactions, and dose-related issues. The most common side effects are mild and dose-related: occasional GI upset (nausea, mild cramping) at higher doses, particularly with concentrated icariin extracts; mild headaches in the first 1-2 weeks of use, especially at higher doses; occasional mild agitation, irritability, or insomnia, particularly with evening dosing; mild flushing or feeling warm, which is consistent with the herb's vasodilatory effects; and occasional rapid heartbeat or palpitations at higher doses. These effects are typically mild and self-limited and resolve with dose reduction or time. More significant side effects at high doses or in susceptible individuals include hypotension (particularly orthostatic), tachycardia, cardiac arrhythmia risk (rare but theoretically possible given cardiovascular effects), mild mania or hypomanic symptoms in susceptible individuals (reported in a small number of case reports at very high doses), and rare allergic reactions including skin rash and respiratory symptoms. At very high doses, Epimedium can produce significant cardiovascular stimulation and symptomatic hypotension that warrants immediate discontinuation. The most clinically important drug interaction is with pharmaceutical PDE5 inhibitors — sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), avanafil (Stendra). Epimedium has weak but real PDE5 inhibitory activity, and combination with pharmaceutical PDE5 inhibitors produces additive effects that can result in significant hypotension, priapism (prolonged erection requiring emergency medical treatment), and cardiovascular instability. Do not combine Epimedium with pharmaceutical PDE5 inhibitors without medical supervision. A much more dangerous drug interaction is with organic nitrates — nitroglycerin, isosorbide dinitrate, isosorbide mononitrate — used for angina, heart failure, and some acute cardiovascular conditions. The combination of Epimedium's PDE5 inhibition with nitrate-mediated NO release can produce severe, potentially fatal hypotension. This interaction is well-established for pharmaceutical PDE5 inhibitors and is theoretically present with Epimedium-derived icariin, though the magnitude is much smaller. Users on nitrates should avoid Epimedium entirely, and any user who might be prescribed nitrates for an acute cardiovascular event should inform their emergency medical team about current Epimedium use. Other clinically relevant drug interactions include additive effects with antihypertensive medications (ACE inhibitors, ARBs, beta blockers, calcium channel blockers, diuretics — monitor blood pressure during initiation), theoretical effects with anticoagulants (warfarin, DOACs) and antiplatelet agents (aspirin, clopidogrel) due to mild antiplatelet activity of icariin, though no clinically significant bleeding has been documented at standard doses, and theoretical effects on hepatically metabolized medications through modest CYP450 modulation. Drug interactions with selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and other antidepressants are generally not problematic at standard doses, though higher doses may produce additive serotonergic or noradrenergic effects in sensitive individuals. Pregnancy is a strong contraindication due to the herb's estrogenic and hormonal effects, which could theoretically affect fetal development. Breastfeeding is contraindicated due to the lack of safety data and the potential for hormonal effects on the nursing infant. Children should not use Epimedium without pediatric medical supervision for specific rare indications. Elderly users — a major target population for the herb's traditional indications — should start at half the adult dose due to increased sensitivity to orthostatic hypotension and potential CNS effects. People with cardiovascular disease, particularly structural heart disease, hypertrophic cardiomyopathy, severe coronary artery disease, or recent myocardial infarction, should use Epimedium cautiously or avoid high doses entirely. People with estrogen-sensitive conditions — breast cancer (current or history), endometrial cancer, uterine fibroids, endometriosis — should avoid Epimedium due to the SERM-like estrogenic activity, though the effect is modest compared with pharmaceutical estrogens. People with thyroid disease should use cautiously as some theoretical interactions exist. Discontinue 2 weeks before elective surgery due to potential effects on blood pressure and bleeding parameters. Seizure disorders are not a clear contraindication but warrant caution given the CNS stimulating effects at higher doses. Finally, product quality varies significantly across Epimedium supplements. Prefer products that specify the icariin content as a percentage (10%, 20%, 40%, 60%, or 98% icariin), identify the specific Epimedium species used (E. sagittatum, E. brevicornum, E. koreanum, etc. — the species differ somewhat in prenylflavonoid profile), specify country of origin, and include third-party testing for heavy metals, pesticides, and microbial contamination. Epimedium has been associated with some concerning adulteration issues in the past — some cheap products have been found contaminated with pharmaceutical PDE5 inhibitors (sildenafil, tadalafil, and their analogs), which would explain unexpected potency but also create dangerous interactions. Purchasing from reputable manufacturers with published testing is essential.

    Contraindications

    Horny Goat Weed (Epimedium) should be avoided or used only under medical supervision in the following populations and situations. Concurrent use of pharmaceutical PDE5 inhibitors (sildenafil/Viagra, tadalafil/Cialis, vardenafil/Levitra, avanafil/Stendra): strong relative contraindication without medical supervision due to additive effects that can cause dangerous hypotension and priapism. Concurrent use of organic nitrates (nitroglycerin, isosorbide dinitrate, isosorbide mononitrate, sodium nitroprusside, amyl nitrite): absolute contraindication — potentially fatal hypotension from combined NO-cGMP pathway activation. Pregnancy: contraindication due to hormonal (SERM-like estrogenic) activity and potential effects on fetal development. Breastfeeding: contraindication due to lack of safety data and potential hormonal effects on nursing infant. Children under 18: not recommended except for specific rare indications under pediatric medical supervision. Estrogen-sensitive conditions — breast cancer (current or history), uterine cancer, ovarian cancer, endometriosis, uterine fibroids: relative contraindication due to SERM-like activity. Discuss with oncologist or gynecologist before use if history of any of these conditions. Severe cardiovascular disease: recent myocardial infarction (within 6 weeks), unstable angina, severe aortic stenosis, hypertrophic cardiomyopathy with outflow tract obstruction, severe heart failure — relative contraindication due to hemodynamic effects. Severe hypotension or history of orthostatic syncope: avoid or use with caution due to additive hypotensive effects. Hypertrophic obstructive cardiomyopathy: contraindication due to theoretical worsening of outflow tract obstruction with vasodilation. Known drug allergy to Berberidaceae family plants (barberry, mahonia, podophyllum): avoid due to potential cross-reactivity. Acute liver disease or severe chronic hepatic impairment: use with caution; monitor liver enzymes. Active peptic ulcer disease: caution due to potential GI effects. Bleeding disorders, active bleeding, or anticipated bleeding events: relative contraindication; discontinue 1-2 weeks before elective surgery. Concurrent use of anticoagulants (warfarin, DOACs) or antiplatelet agents: use with caution due to mild antiplatelet activity of icariin; clinically significant bleeding has not been documented but informs your prescriber. Concurrent use of antihypertensive medications: blood pressure monitoring required during initiation; dose adjustments may be needed. Hyperthyroidism or untreated thyroid disease: caution due to potential interactions with thyroid metabolism. Bipolar disorder, particularly rapid-cycling bipolar or current mania: caution due to potential CNS stimulating effects at high doses, with case reports of mania or hypomania with very high-dose Epimedium use. Active psychosis: caution due to CNS effects. History of priapism or conditions predisposing to priapism (sickle cell disease, multiple myeloma, leukemia, penile deformity): avoid high-dose Epimedium, particularly in combination with other PDE5-active compounds. Narrow-angle glaucoma: theoretical caution due to potential cardiovascular effects. Planned cardiac procedures or surgery: discontinue 1-2 weeks prior. Use of medications that prolong QT interval or cause arrhythmia: theoretical caution. For patients with insulin-dependent diabetes, monitor blood glucose during initiation since Epimedium may have mild effects on glucose metabolism. For patients with autoimmune conditions, particularly those involving estrogen-sensitive pathways (some cases of lupus), use with caution. For athletes in competitive sports, verify that Epimedium and icariin products are not on the banned substances list for your sport (most organizations do not prohibit Epimedium, but confirmation is prudent). A general principle: Horny Goat Weed is a legitimate therapeutic botanical but it is not a casual supplement — it has real pharmacological effects on cardiovascular, hormonal, and bone systems, and users should approach it with appropriate respect. For users with any significant medical conditions or on any significant medications, discuss use with your prescribing clinician before starting. For users with mild indications and no significant medical conditions, begin at the conservative beginner dose and advance carefully based on individual response.

    Check interactions with the Interaction Checker →

    Additional Notes

    Horny Goat Weed dosing depends heavily on the icariin content of the specific preparation, which varies dramatically between products — from less than 1% in poor-quality whole-leaf powders to 98% in purified icariin extracts. Dose based on icariin content, not total product weight. For whole leaf or low-standardization products (5-10% icariin), typical doses are 500-1500 mg twice daily, providing 50-300 mg/day icariin — this is the range appropriate for most general wellness and mild sexual function support. For 20% icariin standardized extract, 250-500 mg twice daily provides 100-200 mg/day icariin — this is the range used in most positive clinical trials for ED and bone health. For 40% icariin extract, 250 mg twice daily provides 200 mg/day icariin with smaller capsule burden. For 60% icariin extract, 167 mg twice daily provides similar total icariin exposure. For 98% icariin extract (essentially purified icariin sold as a supplement), 50-200 mg per dose, 1-3 times daily, provides focused dosing equivalent to the higher-dose clinical trial protocols. Take with food or on a light stomach; food modestly reduces but does not eliminate absorption. Time of day: morning and midday preferred to avoid evening agitation or insomnia. Avoid within 6 hours of bedtime at any dose level above the beginner range. Split dosing (2-3 times daily) is preferable to single daily dosing because of the 2-6 hour plasma half-life of icariin's active metabolites and the advantage of more consistent tissue exposure for chronic effects. For erectile dysfunction, 100-300 mg/day icariin is the evidence-supported range, with effects developing over 4-12 weeks of consistent use. For post-menopausal osteoporosis and bone health, 200-400 mg/day icariin for 6-24 months is the evidence-supported range, with bone density changes measurable on DEXA scan at 12-18 months. For male testosterone support, 100-300 mg/day icariin as part of a broader stack is reasonable. For general wellness and cardiovascular support, lower doses (50-150 mg/day icariin) are appropriate. Starting dose: always start at 25-50% of target maintenance dose for the first 1-2 weeks to assess individual tolerance, particularly cardiovascular response. Maintenance dose: individualize based on response. If tolerating well and seeing benefit at a lower dose, there is no reason to increase. Maximum well-studied daily dose: 600-800 mg icariin in most controlled trials; doses above 1000 mg/day should only be used under medical supervision for specific indications. Cycling: 8-12 weeks on, 1-3 weeks off, is a reasonable pattern for long-term use. Continuous use beyond 6 months without any break has limited formal safety data, though it is common in Chinese clinical practice and appears reasonably tolerated. Missed doses: take as soon as remembered unless close to the next scheduled dose, in which case skip. Do not double-dose. For pediatric use, Epimedium is not recommended. For geriatric use, start at half the adult dose and titrate based on tolerance, with particular attention to orthostatic hypotension risk. For pregnancy and lactation, contraindicated. For renal impairment, no specific dose adjustment typically required. For hepatic impairment, monitor liver enzymes if using high doses long-term (some case reports of mild transaminase elevations with Epimedium). Product quality matters enormously. Prefer products that (1) specify icariin content as a percentage, (2) identify the specific Epimedium species, (3) specify country of origin (most quality material comes from China), (4) provide third-party testing for heavy metals, pesticides, microbial contamination, AND for pharmaceutical PDE5 inhibitor adulteration (this is the most important quality check for Epimedium products specifically), and (5) come from manufacturers with USP, NSF, or equivalent third-party certification. Cheap generic "Horny Goat Weed" products of unspecified icariin content are likely to have inconsistent potency and may have adulteration issues.

    Frequently Asked Questions

    What is the recommended Horny Goat Weed dosage?

    Dosage for Horny Goat Weed varies by protocol. Consult a qualified healthcare provider.

    How often should I take Horny Goat Weed?

    Administration frequency depends on the specific protocol. Consult current research literature.

    Does Horny Goat Weed need to be cycled?

    Cycling requirements depend on the protocol. Follow established research guidelines.

    What are Horny Goat Weed side effects?

    Horny Goat Weed (Epimedium) is generally well-tolerated at typical supplemental doses but is not a trivial herb — it has genuine cardiovascular, endocrine, and vascular effects that warrant attention to side effects, drug interactions, and dose-related issues. The most common side effects are mild and dose-related: occasional GI upset (nausea, mild cramping) at higher doses, particularly with concentrated icariin extracts; mild headaches in the first 1-2 weeks of use, especially at higher doses; occasional mild agitation, irritability, or insomnia, particularly with evening dosing; mild flushing or feeling warm, which is consistent with the herb's vasodilatory effects; and occasional rapid heartbeat or palpitations at higher doses. These effects are typically mild and self-limited and resolve with dose reduction or time. More significant side effects at high doses or in susceptible individuals include hypotension (particularly orthostatic), tachycardia, cardiac arrhythmia risk (rare but theoretically possible given cardiovascular effects), mild mania or hypomanic symptoms in susceptible individuals (reported in a small number of case reports at very high doses), and rare allergic reactions including skin rash and respiratory symptoms. At very high doses, Epimedium can produce significant cardiovascular stimulation and symptomatic hypotension that warrants immediate discontinuation. The most clinically important drug interaction is with pharmaceutical PDE5 inhibitors — sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), avanafil (Stendra). Epimedium has weak but real PDE5 inhibitory activity, and combination with pharmaceutical PDE5 inhibitors produces additive effects that can result in significant hypotension, priapism (prolonged erection requiring emergency medical treatment), and cardiovascular instability. Do not combine Epimedium with pharmaceutical PDE5 inhibitors without medical supervision. A much more dangerous drug interaction is with organic nitrates — nitroglycerin, isosorbide dinitrate, isosorbide mononitrate — used for angina, heart failure, and some acute cardiovascular conditions. The combination of Epimedium's PDE5 inhibition with nitrate-mediated NO release can produce severe, potentially fatal hypotension. This interaction is well-established for pharmaceutical PDE5 inhibitors and is theoretically present with Epimedium-derived icariin, though the magnitude is much smaller. Users on nitrates should avoid Epimedium entirely, and any user who might be prescribed nitrates for an acute cardiovascular event should inform their emergency medical team about current Epimedium use. Other clinically relevant drug interactions include additive effects with antihypertensive medications (ACE inhibitors, ARBs, beta blockers, calcium channel blockers, diuretics — monitor blood pressure during initiation), theoretical effects with anticoagulants (warfarin, DOACs) and antiplatelet agents (aspirin, clopidogrel) due to mild antiplatelet activity of icariin, though no clinically significant bleeding has been documented at standard doses, and theoretical effects on hepatically metabolized medications through modest CYP450 modulation. Drug interactions with selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and other antidepressants are generally not problematic at standard doses, though higher doses may produce additive serotonergic or noradrenergic effects in sensitive individuals. Pregnancy is a strong contraindication due to the herb's estrogenic and hormonal effects, which could theoretically affect fetal development. Breastfeeding is contraindicated due to the lack of safety data and the potential for hormonal effects on the nursing infant. Children should not use Epimedium without pediatric medical supervision for specific rare indications. Elderly users — a major target population for the herb's traditional indications — should start at half the adult dose due to increased sensitivity to orthostatic hypotension and potential CNS effects. People with cardiovascular disease, particularly structural heart disease, hypertrophic cardiomyopathy, severe coronary artery disease, or recent myocardial infarction, should use Epimedium cautiously or avoid high doses entirely. People with estrogen-sensitive conditions — breast cancer (current or history), endometrial cancer, uterine fibroids, endometriosis — should avoid Epimedium due to the SERM-like estrogenic activity, though the effect is modest compared with pharmaceutical estrogens. People with thyroid disease should use cautiously as some theoretical interactions exist. Discontinue 2 weeks before elective surgery due to potential effects on blood pressure and bleeding parameters. Seizure disorders are not a clear contraindication but warrant caution given the CNS stimulating effects at higher doses. Finally, product quality varies significantly across Epimedium supplements. Prefer products that specify the icariin content as a percentage (10%, 20%, 40%, 60%, or 98% icariin), identify the specific Epimedium species used (E. sagittatum, E. brevicornum, E. koreanum, etc. — the species differ somewhat in prenylflavonoid profile), specify country of origin, and include third-party testing for heavy metals, pesticides, and microbial contamination. Epimedium has been associated with some concerning adulteration issues in the past — some cheap products have been found contaminated with pharmaceutical PDE5 inhibitors (sildenafil, tadalafil, and their analogs), which would explain unexpected potency but also create dangerous interactions. Purchasing from reputable manufacturers with published testing is essential.

    Where can I buy Horny Goat Weed?

    Visit our vendor directory to find trusted sources for Horny Goat Weed.

    Free 2026 Peptide Cheat Sheet — 50 pages, PDF

    Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.

    Download Free
    ResearchChemHQ BPC-157 500mcg × 60 capsules bottle
    IN STOCK · COA PER BATCH

    BPC-157 Caps

    60 caps × 500mcg. HPLC + COA on every batch, ≥99% purity. Same molecule as the vials, just oral so it travels. code REDDIT stacks with their 5-vial 20% off and 10-vial 40% off tiers.

    COUPON CODEREDDIT
    Grab a bottle →
    Research use only. Not for human consumption.|BodyHackGuide promotes vendors. We do not sell these products.